| Product Code: ETC7656904 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continues to see a steady flow of netupitant palonosetron FDC import shipments, primarily sourced from top exporting countries including Switzerland, UK, Belgium, USA, and Germany. The market remains relatively competitive with a low concentration level, as indicated by the Herfindahl-Hirschman Index (HHI). Despite a slight decline in the compound annual growth rate (CAGR) from 2020 to 2024 at -2.14%, the market appears to have stabilized with a marginal decrease in growth rate from 2023 to 2024 at -0.41%. This suggests a resilient market for netupitant palonosetron FDC in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Netupitant Palonosetron FDC Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Netupitant Palonosetron FDC Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Netupitant Palonosetron FDC Market - Industry Life Cycle |
3.4 Israel Netupitant Palonosetron FDC Market - Porter's Five Forces |
3.5 Israel Netupitant Palonosetron FDC Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Israel Netupitant Palonosetron FDC Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Israel Netupitant Palonosetron FDC Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chemotherapy-induced nausea and vomiting (CINV) |
4.2.2 Growing adoption of combination therapies for better management of CINV |
4.2.3 Rising healthcare expenditure and focus on improving patient outcomes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Limited awareness and accessibility of netupitant palonosetron FDC in Israel |
4.3.3 Presence of alternative treatments for CINV management |
5 Israel Netupitant Palonosetron FDC Market Trends |
6 Israel Netupitant Palonosetron FDC Market, By Types |
6.1 Israel Netupitant Palonosetron FDC Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Netupitant Palonosetron FDC Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Israel Netupitant Palonosetron FDC Market Revenues & Volume, By Flakes, 2022 - 2032F |
6.1.4 Israel Netupitant Palonosetron FDC Market Revenues & Volume, By Capsules, 2022 - 2032F |
6.1.5 Israel Netupitant Palonosetron FDC Market Revenues & Volume, By Other, 2022 - 2032F |
6.2 Israel Netupitant Palonosetron FDC Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Netupitant Palonosetron FDC Market Revenues & Volume, By Retail Pharmacy, 2022 - 2032F |
6.2.3 Israel Netupitant Palonosetron FDC Market Revenues & Volume, By Online Pharmacy, 2022 - 2032F |
7 Israel Netupitant Palonosetron FDC Market Import-Export Trade Statistics |
7.1 Israel Netupitant Palonosetron FDC Market Export to Major Countries |
7.2 Israel Netupitant Palonosetron FDC Market Imports from Major Countries |
8 Israel Netupitant Palonosetron FDC Market Key Performance Indicators |
8.1 Number of healthcare facilities offering netupitant palonosetron FDC |
8.2 Patient satisfaction levels with the efficacy of the drug |
8.3 Rate of adoption of combination therapies for CINV management |
9 Israel Netupitant Palonosetron FDC Market - Opportunity Assessment |
9.1 Israel Netupitant Palonosetron FDC Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Israel Netupitant Palonosetron FDC Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Israel Netupitant Palonosetron FDC Market - Competitive Landscape |
10.1 Israel Netupitant Palonosetron FDC Market Revenue Share, By Companies, 2025 |
10.2 Israel Netupitant Palonosetron FDC Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here